socalTECH

APRIL 29, 2021

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Westlake Village 113

Westlake Village Thousand Oaks Funding CalTech 113

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. The startup is led by Sanjay D. to its board of directors. READ MORE>>.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

DECEMBER 31, 2012

What was Southern California's technology community most interested in 2012? in the company's efforts to start a commercial space tourism industry. in the company's efforts to start a commercial space tourism industry. venture capital exits in. generation of startups. As part of our.

Southern California 211

Southern California Thousand Oaks Incubator SpaceX 211